SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 131 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $312,000 | +25.8% | 20,796 | +2.0% | 0.00% | – |
Q1 2016 | $248,000 | -36.9% | 20,383 | -17.4% | 0.00% | -100.0% |
Q4 2015 | $393,000 | +68.7% | 24,686 | +166.0% | 0.00% | – |
Q4 2014 | $233,000 | -37.5% | 9,282 | -22.7% | 0.00% | -100.0% |
Q3 2014 | $373,000 | – | 12,003 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |